{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:42:01Z","timestamp":1791319321769,"version":"4.3.1"},"reference-count":114,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1159\/000329188","type":"journal-article","created":{"date-parts":[[2011,7,11]],"date-time":"2011-07-11T06:48:27Z","timestamp":1310366907000},"page":"279-294","source":"Crossref","is-referenced-by-count":218,"title":["Pancreatogenic Diabetes: Special Considerations for Management"],"prefix":"10.1016","volume":"11","author":[{"given":"YunFeng","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana K.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1159\/000329188_bib1","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc11-S062","article-title":"Diagnosis and classification of diabetes","volume":"34","author":"American Diabetes Association","year":"2011","journal-title":"Diab Care"},{"key":"10.1159\/000329188_bib2","unstructured":"Centers for Disease Control. National Diabetes Fact Sheet, 2007. http:\/\/www.cdc.gov\/ diabetes\/pubs\/pdf\/ndfs_2007.pdf. Updated 2007. Accessed 1\/26\/10."},{"key":"10.1159\/000329188_bib3","series-title":"Diabetes Secondary to Pancreatopathy. Proceedings of the Post EASD International Symposium on Diabetes Secondary to Pancreatopathy, Padova, 21\u201322 September 1987. International Congress Series 762","first-page":"35","article-title":"Diabetes secondary to pancreatopathy: new pancreatopathy","author":"Tiengo","year":"1988"},{"key":"10.1159\/000329188_bib4","series-title":"Diabetes Secondary to Pancreatopathy. Proceedings of the Post EASD International Symposium on Diabetes Secondary to Pancreatopathy, Padova, 21\u201322 September 1987, International Congress Series 762","first-page":"211","article-title":"Diabetes secondary to pancreatopathy: an example of brittle diabetes","author":"lberti","year":"1988"},{"key":"10.1159\/000329188_bib5","series-title":"Joslin's Diabetes Mellitus","article-title":"Secondary forms of diabetes","author":"Ganda","year":"1994"},{"key":"10.1159\/000329188_bib6","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0140-6736(86)91846-5","article-title":"Tropical or malnutrition-related diabetes: a real syndrome?","volume":"1","author":"Abu-Bakare","year":"1986","journal-title":"Lancet"},{"key":"10.1159\/000329188_bib7","series-title":"The Pancreas","first-page":"688","article-title":"Tropical chronic pancreatitis","author":"Mohan","year":"1998"},{"issue":"suppl 2","key":"10.1159\/000329188_bib8","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.2337\/dc08-s244","article-title":"Is pancreatic (type 3c) diabetes underdiagnosed and misdiagnosed?","volume":"31","author":"Hardt","year":"2008","journal-title":"Diab Care"},{"key":"10.1159\/000329188_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2047-783X-14-3-118","article-title":"Determinants of exocrine pancreatic function as measured by fecal elastase-1 concentrations in patients with diabetes mellitus","volume":"14","author":"Ewald","year":"2009","journal-title":"Eur J Med Res"},{"key":"10.1159\/000329188_bib10","first-page":"153","article-title":"Chronic pancreatitis:, clinical features and medical management","volume":"81","author":"Bank","year":"1986","journal-title":"Am J Gastroenterol"},{"key":"10.1159\/000329188_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF01271165","article-title":"B-cell function in patients with chronic pancreatitis and its relation to exocrine pancreatic function","volume":"23","author":"Nyboe Andersen","year":"1982","journal-title":"Diabetologia"},{"key":"10.1159\/000329188_bib12","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1053\/gast.2000.19286","article-title":"Risk factors for diabetes mellitus in chronic pancreatitis","volume":"119","author":"Malka","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1159\/000329188_bib13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s002680020337","article-title":"Pancreatic resection: effects on glucose metabolism","volume":"25","author":"Slezak","year":"2001","journal-title":"World J Surg"},{"key":"10.1159\/000329188_bib14","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00000658-200211000-00011","article-title":"Long-term results of distal pancreatectomy for chronic pancreatitis in 90 patients","volume":"236","author":"Hutchins","year":"2002","journal-title":"Ann Surg"},{"key":"10.1159\/000329188_bib15","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1007\/s11605-008-0560-5","article-title":"Distal pancreatectomy: incidence of postoperative diabetes","volume":"12","author":"King","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1159\/000329188_bib16","first-page":"361","article-title":"The incidence and clinical relevance of chronic inflammation in the pancreas in autopsy material","volume":"86","author":"Olsen","year":"1978","journal-title":"Acta Pathol Microbiol Scand A"},{"key":"10.1159\/000329188_bib17","series-title":"The Pancreas","first-page":"672","article-title":"Alcoholic chronic pancreatitis","author":"Worning","year":"1998"},{"key":"10.1159\/000329188_bib18","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/00365520510023116","article-title":"Prevalence and determinants of exocrine pancreatitic insufficiency among older adults: results of a population-based study","volume":"40","author":"Rothenbacher","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1159\/000329188_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.amjsurg.2008.10.023","article-title":"Surgical outcomes following pancreatic resection at a low-volume community hospital: do all patients need to be sent to a regional cancer center?","volume":"198","author":"Cunningham","year":"2009","journal-title":"Am J Surg"},{"key":"10.1159\/000329188_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/107327480801500403","article-title":"Outcomes following resection of pancreatic adenocarcinoma: 20-year experience at a single institution","volume":"15","author":"Helm","year":"2008","journal-title":"Cancer Control"},{"key":"10.1159\/000329188_bib21","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2337\/dc10-1279","article-title":"Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes. A technical review","volume":"33","author":"Moran","year":"2010","journal-title":"Diab Care"},{"key":"10.1159\/000329188_bib22","series-title":"The Discovery of Insulin","author":"Bliss","year":"1984"},{"key":"10.1159\/000329188_bib23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2337\/diabetes.31.4.346","article-title":"Insulin sensitivity, binding, and kinetics in pancreatogenic and type 1 diabetes","volume":"31","author":"Nosadini","year":"1982","journal-title":"Diabetes"},{"key":"10.1159\/000329188_bib24","series-title":"Automation in Analytic Chemistry","first-page":"486","article-title":"Manual feedback technique for control of glucose concentration","author":"Andres","year":"1966"},{"key":"10.1159\/000329188_bib25","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1749-6632.1959.tb44923.x","article-title":"Influences of glucose loading and of injected insulin on hepatic glucose output","volume":"82","author":"Steele","year":"1959","journal-title":"Ann N Y Acad Sci"},{"key":"10.1159\/000329188_bib26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0002-9610(86)90023-1","article-title":"Reversal of abnormal glucose metabolism in chronic pancreatitis by administration of pancreatic polypeptide","volume":"151","author":"Sun","year":"1986","journal-title":"Am J Surg"},{"key":"10.1159\/000329188_bib27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00000658-198908000-00003","article-title":"Pancreatic structure and glucose tolerance in a longitudinal study of experimental pancreatitis-induced diabetes","volume":"210","author":"Yeo","year":"1989","journal-title":"Ann Surg"},{"key":"10.1159\/000329188_bib28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/1097-0142(19910115)67:2<486::AID-CNCR2820670228>3.0.CO;2-1","article-title":"Insulin secretion and action in patients with pancreatic cancer","volume":"67","author":"Cerosimo","year":"1991","journal-title":"Cancer"},{"key":"10.1159\/000329188_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/mpa.0b013e31805d01b0","article-title":"Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis","volume":"35","author":"Andersen","year":"2007","journal-title":"Pancreas"},{"key":"10.1159\/000329188_bib30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1203\/00006450-199505000-00007","article-title":"Elevated hepatic glucose production in children with cystic fibrosis","volume":"37","author":"Kien","year":"1995","journal-title":"Pediatr Res"},{"key":"10.1159\/000329188_bib31","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1210\/jcem-47-3-556","article-title":"Impaired pancreatic polypeptide secretion in chronic pancreatitis","volume":"47","author":"Sive","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1159\/000329188_bib32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00000658-198708000-00006","article-title":"Plasma cholecystokinin and pancreatic polypeptide after radical pancreaticoduodenectomy with Billroth I and Billroth II types of reconstruction","volume":"206","author":"Inoue","year":"1986","journal-title":"Ann Surg"},{"key":"10.1159\/000329188_bib33","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0016-5085(80)90370-4","article-title":"Hormonal abnormalities of the pancreas and gut in cystic fibrosis","volume":"79","author":"Adiran","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1159\/000329188_bib34","first-page":"661","article-title":"The effect of pancreatic polypeptide infusion on glucose tolerance and insulin response in longitudinally studied pancreatitis-induced diabetes","volume":"107","author":"Bastidas","year":"1990","journal-title":"Surgery"},{"key":"10.1159\/000329188_bib35","first-page":"119","article-title":"Reversal of abnormal glucose production after pancreatic resection by pancreatic polypeptide administration in man","volume":"104","author":"Seymour","year":"1988","journal-title":"Surgery"},{"key":"10.1159\/000329188_bib36","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1210\/jc.81.10.3566","article-title":"Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis","volume":"81","author":"Brunicardi","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1159\/000329188_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00006676-198601000-00007","article-title":"Exocrine pancreatic function in oleic acid-induced pancreatic insufficiency in rats","volume":"1","author":"Mundlos","year":"1986","journal-title":"Pancreas"},{"key":"10.1159\/000329188_bib38","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0022-4804(89)90159-5","article-title":"In vitro hepatic insulin resistance in chronic pancreatitis in the rat","volume":"46","author":"Seymour","year":"1989","journal-title":"J Surg Res"},{"key":"10.1159\/000329188_bib39","series-title":"Gastrointestinal Endocrinology","first-page":"321","article-title":"Pancreatic polypeptide and glucose metabolism","author":"Seymour","year":"1999"},{"key":"10.1159\/000329188_bib40","first-page":"1128","article-title":"Reversal of in vitro hepatic insulin resistance in chronic pancreatitis by pancreatic polypeptide in the rat","volume":"106","author":"Goldstein","year":"1989","journal-title":"Surgery"},{"key":"10.1159\/000329188_bib41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0002-9610(99)80117-2","article-title":"Alterations in hepatocyte insulin binding in chronic pancreatitis: effects of pancreatic polypeptide","volume":"169","author":"Seymour","year":"1995","journal-title":"Am J Surg"},{"key":"10.1159\/000329188_bib42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/jsre.1998.5284","article-title":"Overexpression of hepatic pancreatic polypeptide receptors in chronic pancreatitis","volume":"76","author":"Seymour","year":"1998","journal-title":"J Surg Res"},{"key":"10.1159\/000329188_bib43","first-page":"168","article-title":"Insulin receptor gene expression in chronic pancreatitis: the effect of pancreatic polypeptide","volume":"48","author":"Spector","year":"1997","journal-title":"Surg Forum"},{"key":"10.1159\/000329188_bib44","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/00000658-199406000-00011","article-title":"Insulin regulation of hepatic glucose transporter protein is impaired in chronic pancreatitis","volume":"219","author":"Andersen","year":"1994","journal-title":"Ann Surg"},{"key":"10.1159\/000329188_bib45","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/00006676-200103000-00010","article-title":"Impaired hepatocyte glucose transport protein (GLUT2) internalization in chronic pancreatitis","volume":"22","author":"Nathan","year":"2001","journal-title":"Pancreas"},{"key":"10.1159\/000329188_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000083638","article-title":"Insulin receptor and glucose transporter 2 proteins form a complex on the rat hepatocyte membrane","volume":"15","author":"Eisenberg","year":"2005","journal-title":"Cell Physiol Biochem"},{"key":"10.1159\/000329188_bib47","series-title":"Gastrointestinal Endocrinology","first-page":"321","article-title":"Pancreatic Polypeptide and glucose metabolism","author":"Seymour","year":"1999"},{"key":"10.1159\/000329188_bib48","first-page":"488","article-title":"Pancreatic polypeptide","volume":"vol 3","author":"Kono","year":"2004"},{"key":"10.1159\/000329188_bib49","doi-asserted-by":"crossref","first-page":"778","DOI":"10.7326\/0003-4819-83-6-778","article-title":"Glucagon secretion in acute and chronic pancreatitis","volume":"83","author":"Donowitz","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.1159\/000329188_bib50","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF00275269","article-title":"Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution","volume":"19","author":"Ebert","year":"1980","journal-title":"Diabetologia"},{"key":"10.1159\/000329188_bib51","doi-asserted-by":"crossref","first-page":"E324","DOI":"10.1152\/ajpendo.00059.2006","article-title":"Increased post-prandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution","volume":"292","author":"Knop","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1159\/000329188_bib52","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00000658-197610000-00002","article-title":"Pancreatectomy for chronic pancreatitis","volume":"184","author":"Frey","year":"1976","journal-title":"Ann Surg"},{"key":"10.1159\/000329188_bib53","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF01658311","article-title":"Results of partial and total pancreatectomy in 117 patients with chronic pancreatitis","volume":"5","author":"Gall","year":"1981","journal-title":"World J Surg"},{"key":"10.1159\/000329188_bib54","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2337\/diacare.8.4.323","article-title":"The prevalence of retinopathy is similar in diabetes mellitus secondary to chronic pancreatitis with or without pancreatectomy and in idiopathic diabetes mellitus","volume":"8","author":"Couet","year":"1985","journal-title":"Diab Care"},{"key":"10.1159\/000329188_bib55","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.gassur.2004.08.015","article-title":"Improved outcomes for benign disease with limited pancreatic head resection","volume":"9","author":"Aspelund","year":"2005","journal-title":"J Gastrointest Surg"},{"key":"10.1159\/000329188_bib56","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canlet.2004.11.011","article-title":"Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer","volume":"224","author":"Berstein","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1159\/000329188_bib57","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2337\/diacare.29.02.06.dc05-1267","article-title":"Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1","volume":"29","author":"Riddle","year":"2006","journal-title":"Diab Care"},{"key":"10.1159\/000329188_bib58","unstructured":"Masharani U, German MS: Pancreatic hormones and diabetes mellitus; in Gardner DG, Shoback D (eds): Greenspan's Basic and Clinical Endocrinology (8e: http:\/\/www. accessmedicine.com\/content.aspx?aID = 2633151)."},{"key":"10.1159\/000329188_bib59","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nrendo.2010.49","article-title":"Adjunct therapy for type 1 diabetes mellitus","volume":"6","author":"Lebovitz","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1159\/000329188_bib60","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1159\/000329188_bib61","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1159\/000329188_bib62","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1056\/NEJM199305203282001","article-title":"Pancreatitis and the risk of pancreatic cancer","volume":"328","author":"Lowenfels","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1159\/000329188_bib63","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bpg.2010.02.007","article-title":"Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection","volume":"24","author":"Raimondi","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1159\/000329188_bib64","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/sj.bjc.6602619","article-title":"Type 2 diabetes and pancreatic cancer: a meta-analysis of 36 studies","volume":"92","author":"Huxley","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1159\/000329188_bib65","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/jnci\/89.18.1360","article-title":"Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark","volume":"89","author":"Wideroff","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1159\/000329188_bib66","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1159\/000329188_bib67","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MPA.0b013e318209e05d","article-title":"Diabetes and pancreatic cancer: chicken or egg?","volume":"40","author":"Magruder","year":"2011","journal-title":"Pancreas"},{"key":"10.1159\/000329188_bib68","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1001\/archinte.166.17.1871","article-title":"Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan","volume":"166","author":"Inoue","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1159\/000329188_bib69","first-page":"412","article-title":"Association of markers of insulin and glucose control with subsequent colorectal cancer risk","volume":"12","author":"Saydah","year":"2003","journal-title":"Cancer Epidemiol Biomarker Prevent"},{"key":"10.1159\/000329188_bib70","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s10552-004-1050-z","article-title":"Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study","volume":"15","author":"Batty","year":"2004","journal-title":"Cancer Causes Control"},{"key":"10.1159\/000329188_bib71","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.293.2.194","article-title":"Fasting serum glucose level and cancer risk in Korean men and women","volume":"293","author":"Jee","year":"2005","journal-title":"JAMA"},{"key":"10.1159\/000329188_bib72","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1001\/jama.294.22.2872","article-title":"Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers","volume":"294","author":"Stolzenberg-Solomon","year":"2005","journal-title":"JAMA"},{"key":"10.1159\/000329188_bib73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-009-1556-8","article-title":"Pancreatic duct replication is increased with obesity and type 2 diabetes in humans","volume":"53","author":"Butler","year":"2010","journal-title":"Diabetologia"},{"key":"10.1159\/000329188_bib74","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signaling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1159\/000329188_bib75","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1158\/1078-0432.CCR-09-2229","article-title":"Crosstalk between insulin\/insulin-like growth factor-1 receptors and G-protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer","volume":"16","author":"Rozengurt","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1159\/000329188_bib76","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/13813450801969715","article-title":"The role of insulin receptors and IGF-I receptors in cancer and other diseases","volume":"114","author":"Frasca","year":"2008","journal-title":"Arch Physiol Biochem"},{"key":"10.1159\/000329188_bib77","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2174\/138161207780249173","article-title":"The role of insulin receptor isoforms and hybrid insulin\/IGF-I receptors in human cancer","volume":"13","author":"Belfiore","year":"2007","journal-title":"Curr Pharm Des"},{"issue":"pii","key":"10.1159\/000329188_bib78","first-page":"4","article-title":"Diabetes, insulin treatment, and cancer risk: what is the evidence?","volume":"2","author":"Azar","year":"2010","journal-title":"F1000 Med Rep"},{"key":"10.1159\/000329188_bib79","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00006676-200010000-00014","article-title":"Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression","volume":"21","author":"Ding","year":"2000","journal-title":"Pancreas"},{"key":"10.1159\/000329188_bib80","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00006676-200308000-00007","article-title":"Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case-control study in northern Italy","volume":"27","author":"Bonelli","year":"2003","journal-title":"Pancreas"},{"key":"10.1159\/000329188_bib81","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2337\/diacare.29.02.06.dc05-1558","article-title":"Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin","volume":"29","author":"Bowker","year":"2006","journal-title":"Diab Care"},{"key":"10.1159\/000329188_bib82","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.annepidem.2009.11.010","article-title":"Past medical history and pancreatic cancer risk: results from a multi-center case-control study","volume":"20","author":"Maisonneuve","year":"2010","journal-title":"Ann Epidemiol"},{"key":"10.1159\/000329188_bib83","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"10.1159\/000329188_bib84","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2337\/dc08-2175","article-title":"New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes","volume":"32","author":"Libby","year":"2009","journal-title":"Diab Care"},{"key":"10.1159\/000329188_bib85","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/j.gastro.2009.04.013","article-title":"Antidiabetic therapies affect risk of pancreatic cancer","volume":"137","author":"Li","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1159\/000329188_bib86","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1053\/gast.2001.23258","article-title":"Prevention of pancreatic cancer induction in hamsters by metformin","volume":"120","author":"Schneider","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1159\/000329188_bib87","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1126\/science.1120781","article-title":"The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin","volume":"310","author":"Shaw","year":"2005","journal-title":"Science"},{"key":"10.1159\/000329188_bib88","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1158\/0008-5472.CAN-06-1500","article-title":"Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells","volume":"66","author":"Zakikhani","year":"2006","journal-title":"Cancer Res"},{"key":"10.1159\/000329188_bib89","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1158\/0008-5472.CAN-09-0418","article-title":"Metformin disrupts crosstalk between G-protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth","volume":"69","author":"Kisfalvi","year":"2009","journal-title":"Cancer Res"},{"key":"10.1159\/000329188_bib90","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2004.06.007","article-title":"The LKB1 tumor suppressor negatively regulates mTOR signaling","volume":"6","author":"Shaw","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1159\/000329188_bib91","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.75.103004.142702","article-title":"LKB1-dependent signaling pathways","volume":"75","author":"Alessi","year":"2006","journal-title":"Annu Rev Biochem"},{"key":"10.1159\/000329188_bib92","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jcp.21246","article-title":"Mitogenic signaling pathways induced by G-protein-coupled receptors","volume":"213","author":"Rozengurt","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1159\/000329188_bib93","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1158\/0008-5472.CAN-07-2310","article-title":"Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells","volume":"67","author":"Dowling","year":"2007","journal-title":"Cancer Res"},{"key":"10.1159\/000329188_bib94","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2008.04.008","article-title":"In vitro metformin anti-neoplastic activity in epithelial ovarian cancer","volume":"110","author":"Gotlieb","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1159\/000329188_bib95","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1200\/JCO.2009.19.6410","article-title":"Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer","volume":"27","author":"Jiralerspong","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1159\/000329188_bib96","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00125-010-1937-z","article-title":"Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-\u03b1 in mice","volume":"54","author":"Maida","year":"2011","journal-title":"Diabetologia"},{"key":"10.1159\/000329188_bib97","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2337\/diabetes.49.5.741","article-title":"Insulinotropic glucagon-like peptide-1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas","volume":"49","author":"Stoffers","year":"2000","journal-title":"Diabetes"},{"key":"10.1159\/000329188_bib98","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.2337\/db09-0058","article-title":"Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin","volume":"58","author":"Matveyenko","year":"2009","journal-title":"Diabetes"},{"key":"10.1159\/000329188_bib99","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes","volume":"33","author":"Moran","year":"2010","journal-title":"Diab Care"},{"key":"10.1159\/000329188_bib100","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.2337\/dc10-1824","article-title":"Clinical care guidelines: too much of a good thing?","volume":"33","author":"Kirk","year":"2010","journal-title":"Diab Care"},{"issue":"suppl 1","key":"10.1159\/000329188_bib101","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc11-S011","article-title":"Standards of medical care in diabetes - 2011","volume":"34","author":"American Diabetes Association","year":"2011","journal-title":"Diab Care"},{"key":"10.1159\/000329188_bib102","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1001\/jama.289.17.2254","article-title":"Outpatient insulin therapy in type 1 and type 2 diabetes mellitus","volume":"289","author":"DeWitt","year":"2003","journal-title":"JAMA"},{"key":"10.1159\/000329188_bib103","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7326\/0003-4819-145-2-200607180-00010","article-title":"Narrative review: a rational approach to starting insulin therapy","volume":"145","author":"Mooradian","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1159\/000329188_bib104","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","article-title":"Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"32","author":"Nathan","year":"2009","journal-title":"Diab Care"},{"key":"10.1159\/000329188_bib105","first-page":"978","article-title":"The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes: The Diabetes Control and Complications Trial","volume":"329","author":"Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1159\/000329188_bib106","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"10.1159\/000329188_bib107","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood glucose control with metformin on complication in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"issue":"10","key":"10.1159\/000329188_bib108","doi-asserted-by":"crossref","first-page":"e3363","DOI":"10.1371\/journal.pone.0003363","article-title":"Effect of adjuvant metformin treatment in patients with type 1 diabetes and persistent inadequate glycemic control","volume":"3","author":"Lund","year":"2008","journal-title":"A randomized study. PLoS ONE"},{"key":"10.1159\/000329188_bib109","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1464-5491.1999.00047.x","article-title":"Efficacy and safety of acerbose in the treatment of type 1 diabetes mellitus: a placebo-controlled, double-blind, multicentre study","volume":"16","author":"Riccardi","year":"1999","journal-title":"Diabet Med"},{"key":"10.1159\/000329188_bib110","doi-asserted-by":"crossref","DOI":"10.1177\/193229681100500629","article-title":"Pancreatic polypeptide infusion increases insulin sensitivity and reduces the insulin requirement of patients on insulin pump therapy","author":"Rabiee","year":"2011","journal-title":"J Diab Sci Technol"},{"key":"10.1159\/000329188_bib111","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000073655","article-title":"High prevalence of exocrine pancreatic insufficiency in diabetes mellitus: a multi-center study screening fecal elastase-1 concentrations in 1,021 diabetic patients","volume":"3","author":"Hardt","year":"2003","journal-title":"Pancreatology"},{"key":"10.1159\/000329188_bib112","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1053\/meta.2003.50112","article-title":"Alterations in bone mineral density and bone metabolism in patients with various grades of chronic pancreatitis","volume":"52","author":"Mann","year":"2003","journal-title":"Metabolism"},{"key":"10.1159\/000329188_bib113","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/gut.39.4.580","article-title":"Faecal elastase-1: a novel, highly sensitive, and specific tubeless pancreatic function test","volume":"39","author":"Loser","year":"1996","journal-title":"Gut"},{"key":"10.1159\/000329188_bib114","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.cgh.2007.01.004","article-title":"13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis","volume":"5","author":"Dom\u00ednguez-Mu\u00f1oz","year":"2007","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390311800141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390311800141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T07:13:46Z","timestamp":1592723626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390311800141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":114,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S1424390311800141"],"URL":"https:\/\/doi.org\/10.1159\/000329188","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}